Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
Go back to Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)| (NASDAQ: STRO) | Delayed: 10.94 -0.52 (4.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.46 | 52 Week High | $ | |||
| Open | $11.47 | 52 Week Low | $ | |||
| Day High | $11.47 | P/E | N/A | |||
| Day Low | $10.59 | EPS | $ | |||
| Volume | 363,465 | |||||



